Chronic hepatitis C: Treat or wait? Medical decision making in clinical practice

Yazar: Niederau, Claus, Hüppe, Dietrich, Zehnter, Elmar, Möller, Bernd, Heyne, Renate, Christensen, Stefan, Pfaff, Rainer, Theilmeier, Arno, Alshuth, Ulrich, Mauss, Stefan
Baskı/Yayın Bilgisi 2012

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

Yazar: Roeder, Claudia, Jordan, Sabine, Schulze zur Wiesch, Julian, Pfeiffer-Vornkahl, Heike, Hueppe, Dietrich, Mauss, Stefan, Zehnter, Elmar, Stoll, Sabine, Alshuth, Ulrich, Lohse, Ansgar W, Lueth, Stefan
Baskı/Yayın Bilgisi 2014

Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study

Yazar: Hofmann, Wolf Peter, Mauss, Stefan, Lutz, Thomas, Schober, Andreas, Böker, Klaus, Moog, Gero, Baumgarten, Axel, Pfeiffer-Vornkahl, Heike, Alshuth, Ulrich, Hüppe, Dietrich, Wedemeyer, Heiner, Manns, Michael P., Schott, Eckart
Yayımlandı PLoS One (2015)

Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3

Yazar: Niederau, Claus, Mauss, Stefan, Schober, Andreas, Stoehr, Albrecht, Zimmermann, Tim, Waizmann, Michael, Moog, Gero, Pape, Stefan, Weber, Bernd, Isernhagen, Konrad, Sandow, Petra, Bokemeyer, Bernd, Alshuth, Ulrich, Steffens, Hermann, Hüppe, Dietrich
Baskı/Yayın Bilgisi 2014

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

Yazar: Marcellin, Patrick, Xie, Qing, Woon Paik, Seung, Flisiak, Robert, Piratvisuth, Teerha, Petersen, Jörg, Asselah, Tarik, Cornberg, Markus, Ouzan, Denis, Foster, Graham R., Papatheodoridis, Georgios, Messinger, Diethelm, Regep, Loredana, Bakalos, Georgios, Alshuth, Ulrich, Lampertico, Pietro, Wedemeyer, Heiner
Yayımlandı PLoS One (2020)